China Biologic Products EBITDA margin
Qual é o EBITDA margin de China Biologic Products?
O EBITDA margin de China Biologic Products Holdings, Inc. é 42.45%
Qual é a definição de EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin de empresas na Setor Miscellaneous em LSE em comparação com China Biologic Products
Empresas com ebitda margin semelhantes a China Biologic Products
- Legacy Housing tem EBITDA margin de 42.33%
- Amerigo Resources tem EBITDA margin de 42.34%
- ACNB tem EBITDA margin de 42.36%
- Pharos plc tem EBITDA margin de 42.37%
- Lilis tem EBITDA margin de 42.40%
- Silvercorp Metals tem EBITDA margin de 42.44%
- China Biologic Products tem EBITDA margin de 42.45%
- United Overseas Bank (Singapore) tem EBITDA margin de 42.46%
- First Bancshares Inc Miss tem EBITDA margin de 42.50%
- WEC Inc tem EBITDA margin de 42.51%
- National Grid Plc tem EBITDA margin de 42.51%
- PetroShale tem EBITDA margin de 42.52%
- Divi's Laboratories tem EBITDA margin de 42.52%